BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
PR Newswire•28/10/2026•06:50 ET
0
Key Highlights
- ➤BD launches Liverty TIPS Stent Graft commercially in the U.S.
- ➤ARCH study provides six-month interim results from 177 patients.
- ➤Expandable 6-10 mm diameter supports patient-specific hemodynamic treatment.
- ➤Covered stent lengths span 4-10 cm, longest commercially available.
Expert Statements
Rob Righi, Vice president and general manager, Vascular Platform, Peripheral Intervention at BD
“The Liverty™ TIPS Stent Graft was designed to give physicians more flexibility during TIPS procedures. By offering the longest length TIPs stent graft on the market and tailored shunt diameter sizing, the system helps physicians make real-time treatment decisions for patients with complications of portal hypertension.”
Ziv Haskal, Principal investigator of the ARCH trial and professor of radiology and surgery at the University of Virgina
“I've helped develop a lot of existing TIPS technology. Device innovation is intended to advance every operator's daily expertise. What stands out using the Liverty™ TIPS Stent Graft is the unique ease of delivering the device into position and controlling it during deployment. The ability to accommodate the new range of intended TIPS diameters and longer lengths will help physicians best tailor treatment to each patient.”
BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options PR Newswire
The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients.
Get started
Create a free account to read the full story.